Interestingly, IDH2 is also significantly decreased in hepatocarcinoma (HCC) tissues, probably promoting the formation of metastasis due to a negative correlation with matrix metallopeptidase 9 (MMP9) [151], with a prognostic and predictive role in HCC patients [152,153]. Here, MMP9 is linked to hepatocellular carcinoma.